Loading clinical trials...
Loading clinical trials...
In China, the chronic kidney disease (CKD) incidence rate is as high as 10.8%. Renal replacement therapy plays an critical role in the later stage of CKD and becomes mandatory, as end-stage renal dise...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Affiliated Hospital of Xuzhou Medical University
NCT07157397 · End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD), and more
NCT04381143 · CKD (Chronic Kidney Disease) Stage 5D
NCT05858437 · CKD (Chronic Kidney Disease) Stage 5D
NCT06416761 · AKI, CKD, and more
NCT06738550 · Constipation, Peritoneal Dialysis (PD), and more
The affiliated hospital of Xuzhou Medical University
Xuzhou, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions